[DPHARMA] YoY Cumulative Quarter Result on 31-Dec-2010 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- 42.95%
YoY- -5.17%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 162,405 135,310 138,132 131,437 123,766 122,872 115,551 5.83%
PBT 40,175 35,298 34,728 35,408 38,215 35,340 42,587 -0.96%
Tax -7,900 -9,284 -8,023 -6,739 -7,982 -7,937 -10,544 -4.69%
NP 32,275 26,014 26,705 28,669 30,233 27,403 32,043 0.12%
-
NP to SH 32,275 26,014 26,705 28,669 30,233 27,403 32,043 0.12%
-
Tax Rate 19.66% 26.30% 23.10% 19.03% 20.89% 22.46% 24.76% -
Total Cost 130,130 109,296 111,427 102,768 93,533 95,469 83,508 7.66%
-
Net Worth 181,850 169,354 163,783 156,881 142,975 130,490 113,794 8.11%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 24,293 19,434 24,983 222 24,985 20,822 66,611 -15.46%
Div Payout % 75.27% 74.71% 93.56% 0.77% 82.64% 75.99% 207.88% -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 181,850 169,354 163,783 156,881 142,975 130,490 113,794 8.11%
NOSH 138,817 138,815 138,799 138,832 138,810 138,819 138,774 0.00%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 19.87% 19.23% 19.33% 21.81% 24.43% 22.30% 27.73% -
ROE 17.75% 15.36% 16.31% 18.27% 21.15% 21.00% 28.16% -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 116.99 97.47 99.52 94.67 89.16 88.51 83.27 5.82%
EPS 23.25 18.74 19.24 20.65 21.78 19.74 23.09 0.11%
DPS 17.50 14.00 18.00 0.16 18.00 15.00 48.00 -15.46%
NAPS 1.31 1.22 1.18 1.13 1.03 0.94 0.82 8.11%
Adjusted Per Share Value based on latest NOSH - 138,711
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 16.88 14.07 14.36 13.66 12.87 12.77 12.01 5.83%
EPS 3.36 2.70 2.78 2.98 3.14 2.85 3.33 0.14%
DPS 2.53 2.02 2.60 0.02 2.60 2.16 6.92 -15.42%
NAPS 0.189 0.1761 0.1703 0.1631 0.1486 0.1357 0.1183 8.11%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 2.58 2.13 2.02 2.39 2.40 2.08 2.60 -
P/RPS 2.21 2.19 2.03 2.52 2.69 2.35 3.12 -5.58%
P/EPS 11.10 11.37 10.50 11.57 11.02 10.54 11.26 -0.23%
EY 9.01 8.80 9.52 8.64 9.08 9.49 8.88 0.24%
DY 6.78 6.57 8.91 0.07 7.50 7.21 18.46 -15.36%
P/NAPS 1.97 1.75 1.71 2.12 2.33 2.21 3.17 -7.61%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 26/02/14 25/02/13 22/02/12 23/02/11 23/02/10 24/02/09 21/02/08 -
Price 2.60 2.17 2.12 2.45 2.33 2.20 2.53 -
P/RPS 2.22 2.23 2.13 2.59 2.61 2.49 3.04 -5.09%
P/EPS 11.18 11.58 11.02 11.86 10.70 11.14 10.96 0.33%
EY 8.94 8.64 9.08 8.43 9.35 8.97 9.13 -0.34%
DY 6.73 6.45 8.49 0.07 7.73 6.82 18.97 -15.84%
P/NAPS 1.98 1.78 1.80 2.17 2.26 2.34 3.09 -7.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment